NIPER Raebareli Signs MoU with Roche Pharma India to Strengthen Pharmaceutical Education and Research

NIPER Raebareli Signs MoU with Roche Pharma India to Strengthen Pharmaceutical Education and Research

National Institute of Pharmaceutical Education and Research Raebareli (NIPER Raebareli) signed a Memorandum of Understanding (MoU) with Roche Pharma India to foster academic collaboration and advance pharmaceutical education and research in India. The MoU was signed in the presence of Shri Manoj Joshi, Secretary, Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, at Shastri Bhawan, New Delhi.

This strategic partnership aims to bridge the gap between academic learning and real-world industry practices by equipping students and faculty with valuable insights into the evolving pharmaceutical and regulatory landscape. Under the MoU, Roche and NIPER Raebareli will collaborate on initiatives such as a certificate programme in regulatory affairs for students and industry professionals, guest lecture series by industry experts on emerging trends including AI-driven pharmaceutical research, drug development and healthcare innovation to strengthen practical industry understanding.

Shri Manoj Joshi emphasized that India needs to strengthen its capabilities in regulatory sciences, biologics and AI in pharmaceuticals to achieve a sustained global competitive advantage and consolidate its global position. He said academia-industry collaborations are critical to fulfilling these aspirations.

The collaboration aligns with the Government’s #ViksitBharat vision and the #BiopharmaShakti mission, supporting India’s transition from volume-led pharmaceutical growth to value-driven innovation and reinforcing the country’s global leadership in the biopharmaceutical sector.

The initiative marks an important step toward developing a future-ready workforce and fostering sustainable growth in India’s life sciences ecosystem.